Kantonsspital St.Gallen


Jens Huober

Huober J. Metastastic breast cancer - highlights at ASCO 2006. Breast care 2006; 1:270-273.
Hartmann J T, Oechsle K, Huober J, Jakob A, Azemar M, Horger M, Kanz L, Bokemeyer C. An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcoma. Investigational new drugs 2006; 24:249-53.
Krainick-Strobel U, Majer I, Huber B, Gall C, Krämer B, Gruber I, Fehm T, Huober J, Hierlemann H, Doser M, Meyberg-Solomayer G, Hoffmann J, Wallwiener D, Hahn M. Development of a gel-simulation model and generation of standard tables for the complete extirpation of benign breast lesions with vacuum assisted biopsy under ultrasound guidance. Ultrasound in medicine & biology 2006; 32:1539-44.
Harter P, du Bois A, Schade-Brittinger C, Burges A, Wollschlaeger K, Gropp M, Schmalfeldt B, Huober J, Staehle A, Pfisterer J. Non-enrolment of ovarian cancer patients in clinical trials: reasons and background. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005; 16:1801-5.
Krauss K, Wallwiener D, Huober J. Neue Aspekte der adjuvanten Theraphie beim Mammakarzinom - die Aromatasehemmer. Geburtsh Frauenheilk 2005; 65:803-805.
Pfisterer J, Harter P, Canzler U, Richter B, Jackisch C, Hahmann M, Hasenburg A, Burges A, Loibl S, Gropp M, Huober J, Fink D, Bois A, AGO Ovarian Committee , AGO Ovarian Cancer Study Group (AGO-OVAR) . The role of surgery in recurrent ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2005; 15 Suppl 3:195-8.
Mueck A O, Seeger H, Huober J. Chemotherapy of breast cancer-additive anticancerogenic effects by 2-methoxyestradiol?. Life sciences 2004; 75:1205-10.
Schneeweiss A, Huober J, Sinn H P, von Fournier D, Rudlowski C, Beldermann F, Krauss K, Solomayer E, Hamerla R, Wallwiener D, Bastert G. Gemcitabine, epirubicin and docetaxel as primary systemic therapy in patients with early breast cancer: results of a multicentre phase I/II study. European journal of cancer (Oxford, England : 1990) 2004; 40:2432-8.
Seeger H, Huober J, Wallwiener D, Mueck A O. Inhibition of human breast cancer cell proliferation with estradiol metabolites is as effective as with tamoxifen. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2004; 36:277-80.
Krainick-Strobel U, Bergmann A, Huober J, Wallwiener D. Aktueller Stellenwert des Ultraschalls in der Mammadiagnostik. Geburtsh Frauenheilk 2004; 64:632-633.
Mueck A O, Seeger H, Wallwiener D, Huober J. Is the combination with 2-methoxyestradiol able to reduce the dosages of chemotherapeutices in the treatment of human ovarian cancer? Preliminary in vitro investigations. European journal of gynaecological oncology 2004; 25:699-701.
Schneeweiss A, Bastert G, Huober J, Wallwiener D, Hamerla R, Lichter P. Neoadjuvant therapy with gemcitabine in breast cancer. Oncology (Williston Park, N.Y.) 2004; 18:27-31.
Huober J, Krainick-Strobel U, Kurek R, Wallwiener D. Neoadjuvant endocrine therapy in primary breast cancer. Clinical breast cancer 2004; 5:341-7.
Paepke S, Harbeck N, Jacobs V, Schwarz-Böger U, Pildner v Steinburg S, Fischer T, Diedrich F, Blohmer J, Warm M, Huober J, Wolf C, Eiermann W, Kiechle M. Überblick über die neoadjuvante endokrine Theraphie des rezeptorpositiven Mammakarzinoms der postmenopausalen Frau. Geburtsh Frauenheilk 2004; 64:1290-1298.
Reinartz S, Köhler S, Schlebusch H, Krista K, Giffels P, Renke K, Huober J, Möbus V, Kreienberg R, DuBois A, Sabbatini P, Wagner U. Vaccination of patients with advanced ovarian carcinoma with the anti-idiotype ACA125: immunological response and survival (phase Ib/II). Clinical cancer research : an official journal of the American Association for Cancer Research 2004; 10:1580-7.
Krauss K, Aydeniz B, Dohmen B M, Wehrmann M, Wallwiener D, Huober J. Value of positron emission tomography scan in staging cancers, and an unusual presentation of acute myeloid leukemia. Case 2. Detection of an appendiceal carcinoma by whole-body positron emission tomography after Caesarean section. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004; 22:2966-8.
Huober J, Gruber I, Fehm T. Chemotheraphie des Endometriumkarzinoms. Onkologe 2003; 9:1241-1244.
Wallwiener D, Huober J. St. Gallen 2003 - Was tun?. Frauenarzt 2003; 44:516-517.
Seeger H, Diesing D, Gückel B, Wallwiener D, Mueck A O, Huober J. Effect of tamoxifen and 2-methoxyestradiol alone and in combination on human breast cancer cell proliferation. The Journal of steroid biochemistry and molecular biology 2003; 84:255-7.
Huober J, Wagner U, Wallwiener D. Der Stellenwert von Aromastasehemmern der dritten Generation in der endokrinen Theraphie des Mammakarzinoms - Zeit zum Umdenken. Geburtsh Frauenheilk 2002; 62:15-21.
Volkmann M, Sinn H P, Gaugel D, Frey M, Hajjar Y, Ludwig J, Hänsel S, Bastert G, Wallwiener D, Fiehn W, Zentgraf H, Huober J. Anti-p53 in breast cancer: concordance of different assay procedures and association with p53 antigen expression. Oncology 2002; 63:297-305.
Gückel B, Stumm S, Kayser S, Rentzsch C, Gruber I, Marmé A, Huober J, Meuer S C, Wallwiener D. [CD80-modified tumor cell lines: implications for cell-based vaccinations in breast cancer patients]. Zentralblatt für Gynäkologie 2002; 124:566-73.
Huober J, Wallwiener D. Mammakarzinom in der Schwangerschaft. Geburtsh Frauenheilk 2002; 62:904-906.
Huober J, Meyer A, Wagner U, Wallwiener D. The role of neoadjuvant chemotherapy and interval laparotomy in advanced ovarian cancer. Journal of cancer research and clinical oncology 2002; 128:153-60.
Wagner U, Köhler S, Reinartz S, Giffels P, Huober J, Renke K, Schlebusch H, Biersack H J, Möbus V, Kreienberg R, Bauknecht T, Krebs D, Wallwiener D. Immunological consolidation of ovarian carcinoma recurrences with monoclonal anti-idiotype antibody ACA125: immune responses and survival in palliative treatment. See The biology behind: K. A. Foon and M. Bhattacharya-Chatterjee, Are solid tumor anti-idiotype vaccines ready for prime time? Clin. Cancer Res., 7:1112-1115, 2001. Clinical cancer research : an official journal of the American Association for Cancer Research 2001; 7:1154-62.
Huober J, Meyer A, Wagner U, Wallwiener D. Qualitätssicherung in der operativen Theraphie von Ovarialtumoren. Med. Welt 2001; 52:184-187.
Huober J, Meyer A, Wagner U, Wallwiener D. Primäre Chemotheraphie und Intervalllaparotomie beim fortgeschrittenen Ovarialkarzinom. Med. Welt 2001; 52:101-105.
Meyer A, Huober J, Krainick-Strobel U, Greb R, Wagner U, Wallwiener D. Die neoadjuvante endokrine Theraphie des Mammakarzinoms. Onkologe 2000; 1:67-71.
Huober J, Nakamura S, Meyn R, Roth J A, Mukhopadhyay T. Oral administration of an estrogen metabolite-induced potentiation of radiation antitumor effects in presence of wild-type p53 in non-small-cell lung cancer. International journal of radiation oncology, biology, physics 2000; 48:1127-37.
Huober J, Schneeweiss A, Hohaus S, Wittmann G, Meyer A, Martin S, Goldschmidt H, Bastert G, Haas R, Wallwiener D. Tandem and triple high-dose chemotherapy with autologous stem cell rescue in metastatic breast cancer. Journal of cancer research and clinical oncology 1998; 124:690-4.
Hohaus S, Wallwiener D, Martin S, Voso M T, Huober J, Fersis N, Bastert G, Haas R. Efficacy and toxicity of sequential high-dose therapy with peripheral blood stem cell support in patients with high-risk breast cancer. Seminars in oncology 1998; 25:7-11; discussion 45-8.
Hamann U, Costa S, Goette K, Huober J, Solomayer E, Kaufmann M, Bastert G, Komitowski D. Allelic imbalance in three distinct regions on chromosome 17q in sporadic breast cancer correlates with prognostic parameters. The Breast 1997; 6:5.
Huober J, Grischke E M, Hahn U, Wallwiener D, Bastert G. Post partum Hysterektomie bei 2 Patientinnen mit Placenta percreta. Gynäkolo. prax 1997; 21:685-689.
Huober J, Holz F G, Schmid H, Nölle B, Bellmann C, Krastel H, Wallwiener D, Bastert G. [Paraneoplastic retinopathy in 2 patients with breast carcinoma]. Zentralblatt für Gynäkologie 1997; 119:278-81.
Holz F G, Bellmann C, Steffen H, Nölle B, Huober J, Krastel H, Alexandridis E. [Carcinoma-associated retinopathy in breast carcinoma and carcinoid tumor]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 1997; 94:337-42.
Huober J, Niedermaier N, Drlicek M, Kaufmann M, Hacke W, Bastert G. [Paraneoplastic cerebellar degeneration: case report of a patient with breast carcinoma]. Geburtshilfe und Frauenheilkunde 1996; 56:214-6.
Mende U, Huober J, Schmid H, Winterbauer T, Bastert G, Wannenmacher M. [Metastasis to the sternum or parasternal recurrence of breast carcinoma? Value of sonography]. Der Radiologe 1996; 36:22-30.
Huober J, Sprenger H, Costa S D, Zentgraf H, Schmid H, Kaufmann M, Bastert G. [Prognostic significance of p53 autoantibodies in serum of patients with breast carcinoma]. Zentralblatt für Gynäkologie 1996; 118:560-4.
Costa S, Kaufmann M, Diel I, Eppenberger U, Müller H, Wallwiener D, Schmid H, Fersis N, Huober J, Gremm B, von Minkwitz G, Bastert G. Klinisch relevante Prognosefaktoren beim Mammakarzinom. Klin Lab 1994; 40:1153-1166.
Sinn H P, Schmid H, Junkermann H, Huober J, Leppien G, Kaufmann M, Bastert G, Otto H F. [Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy]. Geburtshilfe und Frauenheilkunde 1994; 54:552-8.
Huober J, Bertram B, Petru E, Kaufmann M, Schmähl D. Metabolism of debrisoquine and susceptibility to breast cancer. Breast cancer research and treatment 1991; 18:43-8.
Huober J, & Scharl T (2009). Adjuvante endokrine Therapie in der Prämenopause: Aktuelle Empfehlungen zur Therapie primärer und fortgeschrittener Mammakarzinome. In Kommission Mamma der AGO, vertreten durch Thomssen C (Hrsg.) (pp. 1-9). München, Wien, New York: Zuckschwerdt Verlag.
Huober J, Grischke E M, & Marme A (2009). Ovarialkarzinom. In Die Onkologie (Hrsg. Hiddemann W, Bartram C.R.) (pp. 990-1003). Heidelberg: Springer Medizin Verlag.
page 1 2 3 of 3